Max Planck Innovation
As the central technology transfer company of the Max Planck Society, Max Planck Innovation has helped bridge the gap between science and industry since 1970. We advise and support scientists of the Max Planck Society in the assessment of inventions and filing of patents. We also market patents and technologies to industry, while coaching founders on how to build up new companies based on the research results of the Max Planck Society.
Track record
Since our foundation, we have accompanied over 4,975 inventions and concluded more than 3,000 commercial contracts. Since 1990, 190 newly founded companies (spin-offs) have emerged from the Max Planck Society. Max Planck Innovation advised the vast majority of them. The total revenue for the inventors, the Max Planck Institutes, and the Max Planck Society currently amounts to around 585 million euros. On average, 130 new invention disclosures, as well as 80 patent applications, are added each year.
This record makes Max Planck Innovation one of the world’s leading technology transfer institutions.
Max Planck Innovation concludes around 80 license contracts a year, divided more or less equally between domestic and foreign companies. The type and scope of the licenses vary, as does the form of agreed payments. They extend from one-off payments (upfront payment) and pro-rata sales revenues (license fees) through to milestone payments extending beyond like the development of medicines. At present, several such potential revenues drivers are in development at our industrial partners.
Our success – since we launched our professional support for company founders in 1990 – is clearly visible:
- 190 companies founded
- 140 spin-offs actively accompanied by Max Planck Innovation
- 88 venture capital instances (14 of these with corporate financing) and/or financed by private investors
- 55 MPG participations, 20 of these exits, 13 liquidations and amortizations, thus 22 active participations
- 7 listed companies
- approx. 10,000 new workplaces, all in industries with a bright future
- 21 participations or economic revenue shares of Max Planck Innovation
Life Sciences
Extract:
Köln |
2018 |
|
Berlin |
2008 |
|
USA |
2002 |
|
ARTEMIS Pharmaceuticals GmbH |
Köln/Tübingen |
1998 |
Remscheid |
2021 |
|
Dortmund |
2018 |
|
USA |
2016 |
|
Dortmund |
2022 |
|
Hannover |
2016 |
|
Cerapeutix GmbH |
Dortmund |
2022 |
Wien |
2021 |
|
DeveloGen AG |
Göttingen |
1997 |
FancyLabStuff GmbH |
Dortmund |
2023 |
USA |
2018 |
|
DIREVO Biotech AG |
Köln |
2000 |
Berlin |
1997 |
|
Dresden |
2010 |
|
Hamburg |
1993 |
|
Magdeburg |
2012 |
|
GreenTec GmbH |
Köln |
1997 |
USA |
2018 |
|
Ingenium Pharmaceuticals AG |
Martinsried |
1998 |
Leipzig |
2019 |
|
KINAXO Biotechnologies GmbH |
Martinsried |
2005 |
Dresden |
2012 |
|
metanomics GmbH |
Berlin |
1998 |
Berlin |
2000 |
|
Wendelsheim |
2013 |
|
Martinsried |
1992 |
|
Marburg/Karlsruhe |
2002 |
|
Barcelona |
2021 |
|
Open Sesame Therapeutics GmbH |
Dresden |
2022 |
PlantTec GmbH |
Potsdam |
1996 |
USA |
2017 |
|
Martinsried |
2016 |
|
Protagen AG |
Dortmund |
1999 |
ProteoPlex GmbH |
Bonn |
2017 |
Martinsried |
1998 |
|
Quantitative Surgical GmbH |
Mannheim |
2023 |
Quench Bio Inc. |
USA |
2018 |
QLi5 Therapeutics |
Dortmund |
2020 |
Rheos Medicine Inc. |
USA |
2018 |
Bremen |
2005 |
|
Erlangen |
2022 |
|
Dortmund/Berlin |
2000 |
|
SUGEN Inc. (now: Pfizer Inc.) |
USA |
1991 |
SuppreMol GmbH |
Martinsried |
2002 |
München |
2012 |
|
Tacalyx GmbH |
Berlin |
2019 |
Garching |
2016 |
|
Targenomix GmbH |
Potsdam |
2013 |
Martinsried |
2010 |
|
Toplab GmbH |
Martinsried |
1993 |
U3 Pharma AG |
Martinsried |
2001 |
Dortmund |
2020 |
Chemistry - Physics - Technology
Extract:
Göttingen |
2011 |
|
Göttingen |
2012 |
|
Kaiserslautern |
2014 |
|
Saarbrücken |
1994 |
|
Toronto, Kanada |
2023 |
|
Stuttgart |
2022 |
|
Wildau/Magdeburg |
2008 |
|
Stuttgart |
2021 |
|
Jena |
2016 |
|
München |
2022 |
|
Body Labs, Inc. |
New York |
2010 |
Maastricht |
1996 |
|
Saarbrücken |
2013 |
|
Unterschleissheim |
2009 |
|
DOK Predictive Motion Cueing GmbH |
Tübingen |
2019 |
Stuttgart |
2005 |
|
ECMTEC GmbH (now: EMAG ECM GmbH) |
Holzgerlingen |
2003 |
Köln |
2016 |
|
Ecobus GmbH |
Göttingen |
2021 |
Stuttgart |
2021 |
|
Fountain Hydrothermal Technology GmbH |
München |
2018 |
Heidelberg |
1999 |
|
Berlin |
1990 |
|
Göttingen |
2019 |
|
Intelligent Imaging Solutions GmbH |
Tübingen |
2012 |
Fürth |
2020 |
|
Saarbrücken |
2016 |
|
KonTem GmbH (now: FEI) |
Bonn |
2011 |
Wiesbaden |
2022 |
|
Erlangen |
2018 |
|
Bethesda |
2020 |
|
Berlin |
2000 |
|
Martinsried |
2001 |
|
Tübingen |
2018 |
|
Hamburg |
2022 |
|
Nanofilm Technologie GmbH => now: Accurion GmbH |
Göttingen |
1991 |
Lonsee |
2018 |
|
Martinsried |
2007 |
|
Garching |
2022 |
|
Regensburg |
1997 |
|
München |
2023 |
|
Garching |
2022 |
|
Magdeburg |
2005 |
|
Hamburg |
2021 |
|
München |
2011 |
|
Garching |
2018 |
|
Erlangen |
2016 |
International Network
Max Planck Innovation has been in business for about 50 years. During this time, it has shaped technology transfer substantially. We have established a strong network within the scientific community and industry, comprising professional investors, lawyers, patent attorneys and tax consultants, as well as scientific experts and company representatives from various sectors of industry. We have closed contracts with more than 200 different companies and negotiated seed funding rounds for spin-offs from the Max Planck Society with more than 35 investors.
Our experience and contacts are the fundamental components of our success. We use them to provide optimal support for the scientists and company founders of the Max Planck Institutes, but also to contribute to political debate. In this respect Max Planck Innovation has contributed to novel concepts of the federal government in order to improve the innovation strength of Germany.
Likewise, we are in close contact with other technology transfer institutions, exchanging ideas for the development of professional standards and advancing novel instruments for technology transfer – both at national and international level – for example, as members of the Association of University Technology Managers (AUTM), the Association of European Science & Technology Transfer Professionals (ASTP), the Licensing Executives Society (LES), and TransferAllianz.